Xenotransplantation of hepatocytes in rats with acute liver failure using sirolimus for immunosuppression

Journal of International Medical Research

Volumn 38, Issue 2, 2010, Pages 546-557

  Lytras, D ^a   Papalois, A ^b   Tsaroucha, A K ^a   Papagoras, D ^a   Kyriazanos, J ^a   Lambropoulou, M ^a   Giannakou, N ^c   Galanos, A ^b   Simopoulos, C E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b ELPEN Pharmaceutical Co Inc   (Greece)

^c AGIA OLGA HOSPITAL   (Greece)

Author keywords

Acute liver failure; Cyclosporine; Hepatocytes; Immunosuppression; Rapamycin; Sirolimus; Transplantation; Xenotransplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; CYCLOSPORIN A; DIMETHYLNITROSAMINE; GLUCOSE; POTASSIUM; RAPAMYCIN; SODIUM;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HEPATITIS; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL; LIVER FAILURE; LIVER NECROSIS; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; NONHUMAN; POTASSIUM BLOOD LEVEL; RABBIT; RAT; SCORING SYSTEM; SODIUM BLOOD LEVEL; STRUCTURE ANALYSIS; SURVIVAL RATE; TISSUE CHARACTERIZATION; TREATMENT DURATION; TREATMENT OUTCOME; XENOTRANSPLANTATION;

EID: 77953705617     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800217     Document Type: Article

References (33)

1. Bismuth H, Samuel D, Castaing D, et al: Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 1995; 222: 109-119.
2. Ascher NL, Lake JR, Emond JC, et al: Liver transplantation for fulminant hepatic failure. Arch Surg 1993; 128: 677-682.
3. Lee WM: Acute liver failure in the United States. Semin Liver Dis 2003; 23: 217-226.
4. Calne R: Xenografting-the future of transplantation, and always will be? Xenotransplantation 2005; 12: 5-6.
5. Borel JF: Xenotransplantation in the cyclosporine era. Xenotransplantation 2003; 10: 383-384.
6. Hagelin J: Public opinion surveys about xenotransplantation. Xenotransplantation 2004; 11: 551 - 558.
7. Starzl TE, Klintmalm GB, Porter KA, et al: Liver transplantation with use of cyclosporin A and prednisone. N Engl J Med 1981; 305: 266 - 269.
8. Schrem H, Lück R, Becker T, et al: Update on liver transplantation using cyclosporine. Transplant Proc 2004; 36: 2525-2531.
9. Jiang YP, Ballou LM, Lin RZ: Rapamycin-insensitive regulation of 4e-BP1 in regenerating rat liver. J Biol Chem 2001; 276: 10943-10951.
10. MacDonald AS for the RAPAMUNE Global Study Group: A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001; 71: 271-280.
11. Sabatini DM, Erdjument-Bromage H, Lui M, et al: RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 1994; 78: 35-43.
12. Sehgal SN, Molnar-Kimber K, Ocain TD, et al: Rapamycin: a novel immunosuppressive macrolide. Med Res Rev 1994; 14: 1 - 22.
13. Magee PN: Toxic liver injury; the metabolism of dimethylnitrosamine. Biochem J 1956; 64: 676-682.
14. Bailie MJ, Christie GS: The acute toxic action of dimethylnitrosamine on liver cells. Biochem J 1959; 72: 473 - 479.
15. Papalois A, Arkadopoulos N, Kostopanagiotou G, et al: Experimental xenotransplantation of fresh isolated and cryopreserved pig hepatocytes: a biochemical and morphological study. Transplant Proc 1997; 29: 2096 - 2098.
16. Papagoras D, Papalois A, Tsaroucha A, et al: Beneficial effect of an antibody against interleukin-2 receptor (daclizumab) in an experimental model of hepatocyte xenotransplantation. World J Gastroenterol 2007; 13: 1435-1437.
17. Alvira LG, Herrera N, Salas C, et al: Influence of cyclosporine on graft regeneration and function after liver transplantation: trial in pigs. Transplant Proc 2002; 34: 315-316.
18. Ishak K, Baptista A, Bianchi L, et al: Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
19. Makowka L, Rotstein LE, Falk RE, et al: Allogeneic and xenogeneic hepatocyte transplantation in experimental hepatic failure. Transplantation 1980; 30: 429-435.
20. Makowka L, Rotstein LE, Falk RE, et al: Reversal of toxic and anoxic induced hepatic failure by syngeneic, allogeneic, and xenogeneic hepatocyte transplantation. Surgery 1980; 88: 244-253.
21. Kim WH, Lee JH, Han SU, et al: Can clamping of splenic vessels prevent abrupt increase of portal vein pressure and migration of transplanted hepatocytes to the liver after intrasplenic hepatocyte transplantation? Hepatogastroenterology 1998; 45: 2425-2429.
22. Ahmad TA, Eguchi S, Yanaga K, et al: Role of intrasplenic hepatocyte transplantation in improving survival and liver regeneration after hepatic resection in cirrhotic rats. Cell Transplant 2002; 11: 399-402.
23. Kobayashi N, Ito M, Nakamura J, et al: Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 2000; 31: 851-857.
24. Aoki T, Jin Z, Nishino N, et al: Intrasplenic transplantation of encapsulated hepatocytes decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats.Transplantation 2005; 79: 783-790.
25. Kim WH, Lee JH, Han SU, et al: Systematic analysis of the effects of hepatocyte transplantation on rats with acute liver failure. Hepatogastroenterology 2000; 47: 371-374.
26. Gagandeep S, Rajvanshi P, Sokhi RP, et al: Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis. J Pathol 2000; 191: 78-85.
27. Gupta S, Lee CD, Vemuru RP, et al: 111Indium labeling of hepatocytes for analysis of short- term biodistribution of transplanted cells. Hepatology 1994; 19: 750-757.
28. Andoh TF, Bennett WM: Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens 1998; 7: 265 - 270.
29. Podder H, Stepkowski SM, Napoli KL, et al: Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. J Am Soc Nephrol 2001; 12: 1059-1071.
30. Whiting PH, Woo J, Adam BJ, et al: Toxicity of rapamycin - a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat. Transplantation 1991; 52: 203-208.
31. Francavilla A, Starzl TE, Scotti C, et al: Inhibition of liver, kidney, and intestine regeneration by rapamycin. Transplantation 1992; 53: 496-498.
32. Palmes D, Zibert A, Budny T, et al: Impact of rapamycin on liver regeneration. Virchows Arch 2008; 452: 545-557.
33. Wu YM, Joseph B, Gupta S: Immunosuppression using the mTOR inhibition mechanism affects replacement of rat liver with transplanted cells. Hepatology 2006; 44: 410-419.